Compounds > talinolol
Page last updated: 2024-08-25

talinolol and cyclosporine

talinolol has been researched along with cyclosporine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thakker, DR; Troutman, MD1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Augustijns, P; Deferme, S; Van Gelder, J1
Furubayashi, T; Hidalgo, IJ; Katsumi, H; Sakane, T; Shingaki, T; Yamamoto, A; Yamashita, S1

Other Studies

6 other study(ies) available for talinolol and cyclosporine

ArticleYear
Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
    Pharmaceutical research, 2003, Volume: 20, Issue:8

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blotting, Western; Cells, Cultured; Diffusion; Humans; Intestinal Absorption; Intestinal Mucosa; Models, Biological; Permeability; Pharmaceutical Preparations; Pharmacokinetics

2003
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Inhibitory effect of fruit extracts on P-glycoprotein-related efflux carriers: an in-vitro screening.
    The Journal of pharmacy and pharmacology, 2002, Volume: 54, Issue:9

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Cyclosporine; Fruit; Humans; Plant Extracts; Propanolamines

2002
Nasal delivery of P-gp substrates to the brain through the nose-brain pathway.
    Drug metabolism and pharmacokinetics, 2011, Volume: 26, Issue:3

    Topics: Administration, Intranasal; Adrenergic beta-Antagonists; Animals; ATP Binding Cassette Transporter, Subfamily B; Brain; Cyclosporine; Infusions, Intravenous; Male; Perfusion; Propanolamines; Rats; Rats, Sprague-Dawley; Verapamil

2011